Eversept Partners as of March 31, 2018
Portfolio Holdings for Eversept Partners
Eversept Partners holds 59 positions in its portfolio as reported in the March 2018 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Quality Care Properties | 9.6 | $20M | 1.0M | 19.43 | |
R1 Rcm | 6.5 | $14M | 1.9M | 7.14 | |
Radius Health | 5.8 | $12M | 334k | 35.94 | |
Aerie Pharmaceuticals | 5.5 | $11M | 211k | 54.25 | |
Ablynx Nv | 4.8 | $9.9M | 182k | 54.56 | |
Spdr S&p 500 Etf Tr option | 4.7 | $9.7M | 600.00 | 16225.00 | |
Avexis | 4.6 | $9.7M | 78k | 123.58 | |
Alnylam Pharmaceuticals (ALNY) | 4.5 | $9.4M | 79k | 119.10 | |
GlaxoSmithKline | 4.3 | $8.9M | 227k | 39.49 | |
Arena Pharmaceuticals | 4.2 | $8.7M | 221k | 39.50 | |
Ensign (ENSG) | 4.1 | $8.6M | 326k | 26.34 | |
Zogenix | 3.9 | $8.2M | 205k | 40.05 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $7.3M | 45k | 162.98 | |
Array BioPharma | 2.8 | $5.8M | 358k | 16.32 | |
Sanofi-Aventis SA (SNY) | 2.6 | $5.5M | 138k | 40.08 | |
Nevro (NVRO) | 2.5 | $5.3M | 61k | 86.67 | |
Teligent | 2.5 | $5.2M | 1.6M | 3.36 | |
Sage Therapeutics (SAGE) | 1.9 | $3.9M | 24k | 161.08 | |
BioMarin Pharmaceutical (BMRN) | 1.8 | $3.7M | 46k | 81.07 | |
Tesaro | 1.4 | $2.9M | 52k | 57.14 | |
Abbott Laboratories (ABT) | 1.4 | $2.9M | 48k | 59.92 | |
Argenx Se (ARGX) | 1.4 | $2.9M | 36k | 80.43 | |
Tg Therapeutics (TGTX) | 1.0 | $2.1M | 150k | 14.20 | |
Abiomed | 1.0 | $2.1M | 7.1k | 290.95 | |
Myokardia | 1.0 | $2.1M | 42k | 48.81 | |
Invacare Corporation | 0.8 | $1.7M | 100k | 17.40 | |
Deciphera Pharmaceuticals (DCPH) | 0.8 | $1.7M | 85k | 20.04 | |
Puma Biotechnology (PBYI) | 0.8 | $1.6M | 23k | 68.05 | |
Ascendis Pharma A S (ASND) | 0.8 | $1.6M | 24k | 65.39 | |
Caretrust Reit (CTRE) | 0.7 | $1.5M | 108k | 13.61 | |
Anthem (ELV) | 0.6 | $1.3M | 6.0k | 219.67 | |
Medicines Company | 0.6 | $1.3M | 39k | 32.94 | |
Iovance Biotherapeutics (IOVA) | 0.5 | $1.1M | 65k | 16.91 | |
Haemonetics Corporation (HAE) | 0.5 | $1.1M | 15k | 73.19 | |
eHealth (EHTH) | 0.5 | $1.1M | 75k | 14.31 | |
Centene Corporation (CNC) | 0.5 | $1.1M | 10k | 106.90 | |
Epizyme | 0.5 | $1.0M | 57k | 17.75 | |
Magellan Health Services | 0.5 | $994k | 9.3k | 107.09 | |
Global Blood Therapeutics In | 0.4 | $860k | 18k | 48.31 | |
Align Technology (ALGN) | 0.4 | $753k | 3.0k | 251.00 | |
Amarin Corporation (AMRN) | 0.4 | $753k | 250k | 3.01 | |
Iradimed (IRMD) | 0.3 | $735k | 51k | 14.40 | |
BioCryst Pharmaceuticals (BCRX) | 0.3 | $711k | 149k | 4.77 | |
Affimed Therapeutics B V (AFMD) | 0.3 | $716k | 387k | 1.85 | |
Dynavax Technologies (DVAX) | 0.3 | $596k | 30k | 19.87 | |
Arbutus Biopharma (ABUS) | 0.3 | $588k | 118k | 5.00 | |
Albireo Pharma | 0.3 | $587k | 18k | 32.56 | |
Melinta Therapeutics | 0.3 | $569k | 77k | 7.41 | |
Foamix Pharmaceuticals | 0.3 | $552k | 108k | 5.13 | |
Aquinox Pharmaceuticals | 0.2 | $450k | 32k | 14.07 | |
Ophthotech | 0.2 | $409k | 149k | 2.74 | |
Envision Healthcare | 0.2 | $366k | 9.5k | 38.45 | |
Seaspine Holdings | 0.1 | $313k | 31k | 10.13 | |
Axogen (AXGN) | 0.1 | $183k | 5.0k | 36.60 | |
Dermira | 0.1 | $160k | 20k | 7.99 | |
MiMedx (MDXG) | 0.1 | $103k | 480.00 | 214.58 | |
Quotient | 0.0 | $50k | 11k | 4.76 | |
Celgene Corp right 12/31/2011 | 0.0 | $2.0k | 6.0k | 0.33 | |
Assembly Biosciences (ASMB) | 0.0 | $4.0k | 22.00 | 181.82 |